Amino.Desk

Vesugen

Updated Nov 17, 2026 · Clinical review: pending

Vesugen is one of the Russian short peptides sold as bioregulators. It is marketed for blood vessel support. The evidence comes almost entirely from the group that developed it, and no independent trial has tested it in people.

What it is

Vesugen is a short synthetic peptide.

It belongs to a family of peptides, two to four amino acids long, developed in St. Petersburg by Vladimir Khavinson's group. The idea behind them is that each organ makes its own short regulatory peptides, and that supplying them restores that organ. The group developed each target in two forms, a tissue extract and a short synthetic peptide. The synthetic ones are what research suppliers sell.

What the evidence shows

Vesugen has been tested on human cells taken from the mouth, in a study of cell aging and bone formation presented by the developers' network. That is cell work, not a clinical result. We found no controlled human trial of Vesugen in the sources we reviewed.

For the family as a whole, the record is cell experiments, rodent studies, and small, often unblinded human studies run by the original group. Key findings have not been reproduced by independent teams. The most-cited human study, a 266-person cohort followed for six to eight years, tested thymus and pineal extracts, not this peptide, and was not blinded.

Legal status

Reported dosing

We do not publish a protocol for this compound.

No dose has been established in a controlled human trial. The course schedules that circulate come from the developers' own tradition and from sellers.

Safety

Common questions

What is Vesugen?

A Russian short peptide, one of the Khavinson bioregulators, sold for blood vessel support.

Is Vesugen FDA-approved?

No. It is not approved and is not eligible for pharmacy compounding.

Has Vesugen been tested in people?

We found no controlled human trial. The evidence is cell and animal work from the group that developed it.

Ask an AI about this page

Opens the assistant with a question about this page already typed in. You can edit it before sending.

Ask ChatGPTAsk ClaudeAsk Perplexity

These are outside services. Amino Desk does not control or review their answers, and an AI summary is not medical advice. Check anything important against the sources below.

Sources

Free field guide

Forty peptides and GLP-1s: who can legally get what, how strong the evidence is, and what to check before you pay. Plus one short email a week on what changed.

Leave at any time. We do not sell or share your address. Privacy